0
Get Alert
Please Wait... Processing your request... Please Wait.
You must sign in to sign-up for alerts.

Please confirm that your email address is correct, so you can successfully receive this alert.

Article   |    
THERAPEUTIC RE-ORIENTATION IN SOME DEPRESSIVE STATES: CLINICAL EVALUATION OF A NEW MONO-AMINE OXIDASE INHIBITOR (W-1544-A) (PHENELZINE (NARDIL)
WILLIAM FURST
Am J Psychiatry 1959;116:429-434.
View Author and Article Information

Attending Neuropsychiatrist, East Orange General Hospital, East Orange, N. J.

text A A A
PDF of the full text article.
Abstract

A re-orientation to theory and therapy of some depressive states is slowly coming into sharper focus. The sequence of events developing from the response of a depressed patient to nicotinic acid and its relation to iproniazid is presented. Psychic energizers, mono-amine oxidase inhibitors, serotonin, and nor-epinephrine may have etiologic relationship in depressive disorders. Neurophysiological findings must also be integrated with psychopharmacological researches. A more specific nosological re-classification to recognize that involutional melancholia, manic-depressive states, and reactive depression may vary qualitatively rather than quantitatively is in order. Clinical experience with phenelzine (W-1544-A), a new mono-amine oxidase inhibitor, is presented as to drug characteristics, dosage, side effects, therapeutic effect, and comparability with iproniazid. In a preliminary screening at the private practice level, 69% of 36 patients who completed more than 4 weeks of treatment with W-1544-A showed remission from endogenous depressive states.

Abstract Teaser
Figures in this Article

Your Session has timed out. Please sign back in to continue.
Sign In Your Session has timed out. Please sign back in to continue.
Sign In to Access Full Content
 
Username
Password
Sign in via Athens (What is this?)
Athens is a service for single sign-on which enables access to all of an institution's subscriptions on- or off-site.
Not a subscriber?

Subscribe Now/Learn More

PsychiatryOnline subscription options offer access to the DSM-5 library, books, journals, CME, and patient resources. This all-in-one virtual library provides psychiatrists and mental health professionals with key resources for diagnosis, treatment, research, and professional development.

Need more help? PsychiatryOnline Customer Service may be reached by emailing PsychiatryOnline@psych.org or by calling 800-368-5777 (in the U.S.) or 703-907-7322 (outside the U.S.).

+

References

+
+

CME Activity

There is currently no quiz available for this resource. Please click here to go to the CME page to find another.
Submit a Comments
Please read the other comments before you post yours. Contributors must reveal any conflict of interest.
Comments are moderated and will appear on the site at the discertion of APA editorial staff.

* = Required Field
(if multiple authors, separate names by comma)
Example: John Doe



Web of Science® Times Cited: 15

Related Content
Articles
Books
The American Psychiatric Publishing Textbook of Geriatric Psychiatry, 4th Edition > Chapter 26.  >
The American Psychiatric Publishing Textbook of Geriatric Psychiatry, 4th Edition > Chapter 26.  >
Manual of Clinical Psychopharmacology, 7th Edition > Chapter 1.  >
Dulcan's Textbook of Child and Adolescent Psychiatry > Chapter 46.  >
Dulcan's Textbook of Child and Adolescent Psychiatry > Chapter 46.  >
Topic Collections
Psychiatric News
APA Guidelines